Dr. Arellano, M.D.
Clinical Director
Dr. Arellano serves as Clinical Director of MindScape Retreat in Cozumel, Mexico, where he has personally directed the medical care of more than 900 patients undergoing ibogaine-assisted detoxification. He is recognized in the Mexican medical community as one of the most experienced physicians delivering ibogaine HCl flood-dose protocols under continuous cardiac telemetry.
His clinical work focuses on the intersection of conventional addiction medicine and supervised psychedelic therapy. He developed MindScape's onsite full-spectrum TA-bridging protocol for patients discontinuing antidepressants, benzodiazepines, and opioid agonists prior to flood dose — a protocol that, to our knowledge, is not currently delivered onsite at any other ibogaine facility in North America.
Dr. Arellano is the medical reviewer for MindScape's clinical authority pages, including the onsite taper protocol, the 2026 evidence base, and emergency response protocols. He oversees protocol updates, citation accuracy, and the clinical accuracy of every page referenced as medically reviewed.
Credentials
- M.D., Universidad Autónoma de México
- Board Certified in Addiction Medicine
- Member, International Ibogaine Therapy Alliance (IITA)
- Cardiac monitoring and ACLS certified
Specialties
- Addiction Medicine
- Integrative Medicine
- Psychiatric Pharmacology
- Ibogaine-Assisted Detoxification
Oversight scope
- Pre-treatment medical clearance, EKG and QTc review, lab interpretation
- Flood-dose protocol design and intra-treatment cardiac telemetry oversight
- Onsite total-alkaloid (TA) bridging titration for SSRI/SNRI/benzodiazepine discontinuation
- Emergency response readiness — bradycardia, QTc prolongation, autonomic instability
- Post-treatment integration medication review and prescriber handoff
At a glance
- Experience
- 15+ years in addiction medicine; 10+ years in ibogaine-assisted treatment
- Patient volume
- 900+ ibogaine patients personally treated
- Languages
- English, Spanish
- Memberships
- International Ibogaine Therapy Alliance (IITA) · Mexican College of Addiction Medicine